Table 2.
Prevalence % (95% CI)
|
||||
---|---|---|---|---|
Crude prevalence
|
CR prevalence
|
|||
Age (years) | Female | Male | Female | Male |
0-9 | 0.1% (0, 0.1) | 0.1% (0, 0.1) | NA | NA |
10-19 | 0.4% (0.3, 0.5) | 0.1% (0.2, 0.4) | 0.1% (0.3, 0.6) | 0.4% (0.3, 0.5) |
20-29 | 0.4% (0.4, 0.5) | 0.5% (0.4, 0.6) | 0.8% (0.6, 1.0) | 0.9% (0.6, 1.4) |
30-39 | 0.4% (0.5, 0.8) | 0.8% (0.6, 0.9) | 1.0% (0.8, 1.2) | 1.2% (1.0, 1.4) |
40-49 | 0.8% (0.6, 1.0) | 1.2% (1.0, 1.4) | 1.2% (1.0, 1.4) | 1.8% (1.6, 2.0) |
50-59 | 2.0% (1.7, 2.3) | 2.7% (2.4, 3.0) | 2.8% (2.5, 3.2) | 4.1% (3.7, 4.5) |
60-69 | 3.5% (3.2, 3.9) | 4.5% (4.1, 5.0) | 5.6% (5.1, 6.0) | 6.9% (6.4, 7.4) |
70-79 | 3.7% (3.3, 4.1) | 5.6% (5.0, 6.3) | 7.6% (7.0, 8.2) | 14.1% (13.2, 15.1) |
80+ | 4.2% (3.6, 4.8) | 6.0% (5.0, 7.1) | 9.3% (8.5, 10.2) | 18.3% (16.6, 20.0) |
Overall | 1.4 (1.3, 1.5) | 1.6 (1.5, 1.7) | 2.4 (2.2, 2.7) | 4.0 (3.9, 4.2)* |
NA=Not appropriate for capture-recapture techniques as the number of cases was too small
Compared with crude rate, P<0.0001